期刊文献+

老年高剂量四价流感病毒裂解疫苗的研究 被引量:3

Research and development of high-dose inactivated quadrivalent influenza serial vaccines (split virion) proposed to be used for elderly adults
原文传递
导出
摘要 目的评估老年高剂量四价流感病毒裂解疫苗(A+B套苗)的免疫原性。方法采用江苏金迪克生物技术有限公司研发的四价流感病毒裂解疫苗,以小鼠为动物模型进行免疫原性试验,测定各组抗血凝素抗体滴度,比较高剂量A+B套苗与其他组疫苗的免疫原性差别。结果血凝抑制试验结果表明,高剂量单次免疫组对四型抗原的血凝抑制滴度均高于标准剂量单次免疫组;高剂量A+B套苗的研究中,除高剂量先B苗后A苗组中抗A3的血凝素抗体滴度未显著增加外,其他各组高剂量两次免疫组血凝素抗体滴度均显著高于标准剂量两次免疫组(P〈0.001)。同时发现,不论高剂量还是标准剂量的A+B套苗组中,先B苗后A苗组中抗A型的血凝素抗体滴度明显高于先A苗后B苗组;先A苗后B苗组中,抗B型的血凝素抗体滴度明显高于先B苗后A苗组。在高剂量A+B套苗两次免疫时间的间隔对抗血凝素抗体产生的影响试验中,7 d与10 d免疫间隔的免疫效果优于3 d。结论高剂量四价老年流感疫苗(A+B套苗)分两次注射、免疫间隔7~10 d的方式免疫效果最好,在流感季节可根据A型和B型流感病毒流行监测结果,选择或改变先A苗后B苗或先B苗后A苗使用程序,以增加对人群的保护,是预防老年流感的新方法。 ObjectiveTo evaluate the immunogenicity of high-dose inactivated quadrivalent influenza serial vaccines (split virion) for elderly people.MethodsImmunogenicity assays on mouse as research animal model with inactivated quadrivalent influenza serial vaccines (split virion) were carried out. Then rates of seroconversion and geometric mean hemagglutination inhibition titers (GMTs) at day 21 after the last vaccination among those who received high-dose (HD) A+ B influenza vaccine, were compared with those who received other vaccines by hemagglutination inhibition (HAI) test.ResultsThe result of HAI test showed in HD serial vaccine groups, GMTs for all kinds of HA in the two HD serial vaccine groups were significantly different from that of the two SD serial vaccine groups, respectively (P〈0.0001), but not the titers for A3 in one B dose first group. Further- more, GMTs for strain A in one B dose first groups were significantly higher than that of one B dose first groups in both HD and SD groups, and vice versa in the GMTs for strain B. The result of the assay of the impact of different immunization intervals of HD serial influenza vaccine on immunogenicity indicated that the immunity responses in 7 or 10 d groups were higher than that in 3 d group.ConclusionsIt is a new method to prevent the flu for elderly by HD A+ B serial influenza vaccine, whose HA dose per immunization was reduced into two injections, worked best when the immunization interval was 7-10 d. The protective immunity can be improved by selecting immune procedure of the serial vaccine according to the epidemic type surveillance of influenza virus A and B strains.
作者 余军 杨文彬 杨宪普 帅旗 赵越 张赟 朱实惠 蒋正东 吴建华 赵静 付建林 Yu Jun;Yang Wenbin;Yang Xianpu;Shuai Qi;Zhao Yue;Zhang Yun;Zhu Shihui;Jiang Zhengdong;Wu Jianhua;Zhao Jing;Fu Jianlin(Jiangsu GDK Biological Technology Co.,Lid,Taizhou 225300,China)
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2018年第4期341-346,共6页 Chinese Journal of Experimental and Clinical Virology
关键词 老年人 流感疫苗 四价 高剂量 A+B套苗 Elderly adults Inactivated Influenza vaccine Quadrivalent High-dose A+ B serial
作者简介 通信作者:杨文彬,Email:bam7565@163.com
  • 相关文献

参考文献3

二级参考文献27

  • 1Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinieal efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis,2010,51:997-1004.
  • 2Belshe RB, Coelingh K, Ambrose CS, et al. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine, 2010,28: 21d-9-2156.
  • 3Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin lmmunother,2012,8:81-88.
  • 4Dijkstra F, Donker GA, Wilbrink B, et al. Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiol Infect, 2009,137:473-479.
  • 5Lo YC, Chuang JH, Kuo tfW, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine- mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One, 2013, 8: e58222, doi: 10.1371/ journal, pone. 0058222. Epub 2013 Mar 5.
  • 6Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccein ,2010,28 Suppl 4 : D45-53.
  • 7Traynor K. First quadrivalent flu vaccine approved. Am J Health Syst Pharm ,2012,69:538.
  • 8Block SL, Falloon J, Hirschfield JA, et al. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infeet Dis J ,2012,31:745-751.
  • 9Greenberg DP, Robertson CA, Noss MJ, et al. Safety and immunugenicity of a quadrivalent inactivated influenza vaccine compared tu licensed trivalent inactivated influenza vaccines in adults. Vaccine,2013,31:770-776.
  • 10Luke C J, Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis,2006,12:66-72.

共引文献27

同被引文献34

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部